期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Determinants of the Use of Health Care and Therapeutic Routes of Populations in Rural Senegalese Areas, 2016
1
作者 Abdoul Aziz Ndiaye Awa Ba-diop +7 位作者 maimouna diop Alioune Badara Tall Ousseynou Ka Fatou Ndiaye Omar Sy Sylla Ndeye Fatou Ngom Aladji Madior diop Lamine Gueye Anta Tal Dia 《Open Journal of Preventive Medicine》 2021年第12期439-448,共10页
In Senegal, access to health care for rural populations and therapeutic choices remain problematic. These problems may be synonymous with insufficient financial resources, long waits, ineffective treatments, or drug s... In Senegal, access to health care for rural populations and therapeutic choices remain problematic. These problems may be synonymous with insufficient financial resources, long waits, ineffective treatments, or drug shortage in health structures, leading patients to perform various therapeutic behaviours. The aim of this present study was to identify the therapeutic routes of the patients and the determinants of the different uses of health care in the populations of Ferlo. This descriptive and analytical study was carried out as part of the medical consultation days of the 2016 summer at the university in Widou Thiengoly. All patients who met the selection criteria were enrolled. In total, the 150 participants were mainly animal breeders (63.3%) and housewives (26%), also, most were women (90.7%). The analysis of the therapeutic routes showed that the health post was used as first-line and second-line respectively in 85.3% and 59.3% of the study populations. Traditional medicine and self-medication would be used in the third intention. Therapeutic choices were independent of age (p = 0.94), marital status (p = 0.84) and occupation (p = 0.58). On the other hand, social dimensions, such as tradition, appreciation of efficiency, distance, cost, and gender, also determine the use of health care. Women used health post more frequently than men (p = 0.03) (OR: 3.89, CI95% [1.16 - 12.98]) of the order 3.89. The main reasons for self-medication practice were the treatment of headache or fever (46%) and that of fatigue (26%). The prices were more expensive for health facilities (70.9%) than for traditional healers (70% “not expensive at all”) where the waiting time was considered “not long at all” (70%). 展开更多
关键词 Therapeutic Routes BIOMEDICINE Traditional Medicine Widou Thiengoly
下载PDF
Profile of Plasma Galectin-3 Concentrations, Inflammatory Cytokines Levels and Lymphocytes Status in Breast Cancer under Chemotherapy
2
作者 Doudou Georges Massar Niang Sidy Ka +11 位作者 Jacobus Hendricks Doudou Diouf Folly Mawulolo Gaba Adame Diouf maimouna diop Moustapha Mbow Babacar Faye Rokhaya Ndiaye Diallo Maguette Deme Sylla Niang Ahmadou Deme Babacar Mbengue Alioune Dieye 《Open Journal of Immunology》 2022年第1期1-14,共14页
We investigated relationship between galectin-3 (Gal-3) levels and T lymphocytes apoptosis and the activation rates in breast cancer during chemotherapy. We used plasma samples from 112 women classified into two group... We investigated relationship between galectin-3 (Gal-3) levels and T lymphocytes apoptosis and the activation rates in breast cancer during chemotherapy. We used plasma samples from 112 women classified into two groups: 70 women with breast cancer (BC) and submitted to neoadjuvant chemotherapy (3 cycles) and 42 healthy women used as controls. In the group of BC, blood samples were taken before each cycle of chemotherapy and Gal-3 levels was evaluated by ELISA sandwich. Flow cytometry was used to study T cells apoptosis and activation. Before treatment, median value of Gal-3 was 6.31 ng/ml (range 1.07 - 50.74) in BC and 0.84 ng/ml (range 0.00 - 4.82) in HC. Gal-3 levels were highest in plasmas from BC (p p p = 0.010). In addition, we found a dynamic relationship between gal-3 levels, tumor size and T lymphocytes apoptosis rates during treatment depending to the cure efficiency. We suggest gal-3 plasma concentrations could be used as predictive biomarker for chemotherapy efficiency in breast cancer patients. 展开更多
关键词 GALECTIN-3 T Lymphocyte B Lymphocyte Breast Neoplasms
下载PDF
Predictive Significance of IL-17A Serum Levels during Chemotherapy in Senegalese Women with Cervical Cancer 被引量:2
3
作者 Folly Mawulolo Gaba Babacar Mbengue +12 位作者 maimouna diop Doudou Diouf Sidy Ka Doudou Georges Massar Niang Ramatoulaye Ndiaye Ibrahima Mounkeila Seydou Jean Pascal Demba diop Moustapha Mbow Rokhaya Ndiaye Diallo Maguette Sylla Niang Mbacké Sembene Ahmadou Dem Alioune Dieye 《Open Journal of Immunology》 2019年第4期37-47,共11页
Background and Objectives: Cervical cancer is a leading cause of cancer death in female populations. It is a virally induced carcinoma resulting from sexually transmitted high risk Human Papillomavirus infections (e.g... Background and Objectives: Cervical cancer is a leading cause of cancer death in female populations. It is a virally induced carcinoma resulting from sexually transmitted high risk Human Papillomavirus infections (e.g. HPV-16, HPV-18). Previous studies have shown associations between IL-17A levels in cancer micro-environments and metastasis of tumor cells. In Africa, chemotherapy (CT) is the standard first-line treatment for cervical cancer and the prognosis remains poor for metastatic and recurrent cases. The impact of CT as a treatment option is still unclear. We investigated the prognostic relevance of IL-17A profiles in Cervical cancer patients (CP) patients treated with cisplatin in combination with 5-fluouracil (5FU) for three cycles. Methods: The study included 57 CP and 59 women with no history of malignancy as healthy controls (HC). IL-17A plasma levels were evaluated by ELISA. For each CP, three blood samples were collected at three-week intervals before initiation of the chemotherapy protocol. Results: Before chemotherapy CP showed higher serum levels of IL-17A compared to HCs (p = 0.035). No relation was detected between age and IL-17A levels. We observed a significant increase in serum IL-17A during treatment of the CP group (p Conclusion: Our results suggest that high serum levels of IL-17A are associated with poor responses to classical chemotherapy. However, considering these results to design CC biomarkers, we need further investigations particularly about the relevant prognostic indicator following chemotherapy. 展开更多
关键词 CERVICAL Cancer CHEMOTHERAPY INTERLEUKIN 17A
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部